Metric Finance
LearnFAQ
LearnFAQ

Learn / ALNY

NASDAQ: ALNY

Alnylam Pharmaceuticals (ALNY) stock, explained like you're 5

Alnylam Pharmaceuticals trades on the Nasdaq under the ticker ALNY. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 31.1 billion dollars.

Ticker
ALNY
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Large cap, about 31.1 billion dollars

Is Alnylam Pharmaceuticals a small, medium or large cap company?

Yes. Alnylam Pharmaceuticals is a large cap stock. Its market cap, which is the total value of all its shares, is about 31.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Alnylam Pharmaceuticals makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ALNY stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Alnylam Pharmaceuticals (ALNY) vs. IONS and ARWR: Can Pipeline Growth Restore Confidence After the Guidance Cut? (Yahoo Finance)
  • Alnylam Pharmaceuticals, Inc. (ALNY) Stock Forecasts (Yahoo Finance)
  • Alnylam Pharmaceuticals (NASDAQ:ALNY): Affordable Growth With RNAi Commercial Momentum (ChartMill)
  • If You Invested $1000 In Alnylam Pharmaceuticals Stock 15 Years Ago, You Would Have This Much Today (Benzinga)
  • Alnylam Pharmaceuticals (NASDAQ:ALNY) Share Price, Forecast & Analysis (Stocks Down Under)

Follow ALNY in your daily brief

Each trading day at 5 PM ET we post what happened to Alnylam Pharmaceuticals and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow ALNY

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Alnylam Pharmaceuticals stock

What does Alnylam Pharmaceuticals do?

Alnylam Pharmaceuticals trades on the Nasdaq under the ticker ALNY. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 31.1 billion dollars.

What is the ticker symbol for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals trades under the ticker ALNY on the Nasdaq.

What is Alnylam Pharmaceuticals's market cap?

Alnylam Pharmaceuticals is a large cap stock with a market cap of about 31.1 billion dollars.

How does Alnylam Pharmaceuticals make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ALNY stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ALNY stock every day?

Add ALNY to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow ALNY daily

A free brief on Alnylam Pharmaceuticals and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare ALNY: ALNY vs NVS, ALNY vs AZN, ALNY vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed